XECAN is proud to announce a major milestone in 2025: through our expanding network of strategic partnerships, we have successfully launched 16 new XECAN systems across healthcare facilities throughout Europe.
These new deployments strengthen XECAN’s position as a trusted provider of AI-assisted clinical workflow and patient safety solutions, specializing in advanced Face ID technology and automated accessory verification systems. The newly installed systems are helping clinics improve patient identification, streamline operational efficiency, and enhance treatment safety through intelligent automation.
Powered by XECAN’s advanced Face ID technology, healthcare providers benefit from fast, touchless patient verification integrated directly into existing workflows. In addition, XECAN’s accessory verification solutions support automated tracking and confirmation of treatment-critical accessories, helping reduce manual errors and improve overall patient care standards.
While 2025 marks a significant expansion across Europe, XECAN continues to actively support and deploy systems throughout the United States, where our technologies remain an important part of modern healthcare workflows. Our growing international presence reflects the increasing demand for reliable, AI-driven solutions that improve safety, efficiency, and patient experience in healthcare environments worldwide.
As we continue expanding globally, XECAN remains committed to delivering innovative technologies and building strong partnerships that help healthcare providers operate smarter, safer, and more efficiently.
For more information about XECAN, please get in touch with us:
Email: info@xecan.com
Toll-Free: 1866-469-3226
Int'l: 617-588-0098
Fax: 508-276-0006
About XECAN: XECAN provides AI-assisted clinic solutions to improve clinic workflow, patient tracking, treatment safety, and overall quality of patient care. XECAN is a pioneering company developing innovative AI-assisted oncology solutions that empower healthcare providers to deliver precise and personalized radiation therapy. By seamlessly integrating artificial intelligence into its products, XECAN aims to enhance patient outcomes and treatment efficiency, setting new standards in radiation oncology care. Through continuous research and collaboration, XECAN remains dedicated to advancing the field and ensuring patients receive the most effective and compassionate treatment possible.